Review

Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects

J Dupont and D Le Roith

Clinical Endocrinology Branch, NIDDK, National Institutes of Health, Bethesda MD 20892–1758, USA

Correspondence to:
Dr LeRoith MD, PhD.Clinical Endocrinology Branch, NIDDK, Room 8D12, Building 10, National Institutes of Health, Bethesda, MD 20892–1758 Derek{at}helix.nih.gov

In MCF-7 breast cancer cells, the insulin-like growth factor 1 receptor (IGF-1R) and the oestrogen receptor (ER) are coexpressed and the two signalling systems are engaged in a crosstalk that results in synergistic growth. However, coupling between the signalling cascades is poorly understood. Oestradiol enhances IGF-1R signalling by inducing the expression of insulin receptor substrate 1 (IRS-1), a substrate of the IGF-1R. Oestradiol induced expression of IRS-1 results in enhanced tyrosine phosphorylation of IRS-1 after IGF-1 stimulation, followed by enhanced mitogen activated protein kinase, phosphoinositide 3' kinase, and Akt activation. Oestradiol can also potentiate the effect of IGF-1 on the expression of cyclin D1 and cyclin E, and on the phosphorylation of the retinoblastoma protein (RB). These effects are greatly diminished in SX13 cells, which exhibit a 50% reduction in IGF-1R expression but few functional IGF-1Rs at the surface. Oestradiol and IGF-1 regulate the expression of two cyclin dependent kinase inhibitors, p21 and p27, differently. Whereas IGF-1 increases p21 expression and reduces p27 expression, oestradiol has no effect on p21. In summary, in MCF-7 cells, oestrogen potentiates the effect of IGF-1 on IGF-1R signalling and its effects on certain cell cycle components.

Key Words: breast cancer • oestrogen receptor • insulin-like growth factor 1 receptor • cell cycle

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Law, J. H., Habibi, G., Hu, K., Masoudi, H., Wang, M. Y.C., Stratford, A. L., Park, E., Gee, J. M.W., Finlay, P., Jones, H. E., Nicholson, R. I., Carboni, J., Gottardis, M., Pollak, M., Dunn, S. E. (2008). Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival. Cancer Res. 68: 10238-10246 [Abstract] [Full Text]  
• Ibrahim, Y. H., Byron, S. A., Cui, X., Lee, A. V., Yee, D. (2008). Progesterone Receptor-B Regulation of Insulin-Like Growth Factor-Stimulated Cell Migration in Breast Cancer Cells via Insulin Receptor Substrate-2. Mol Cancer Res 6: 1491-1498 [Abstract] [Full Text]  
• Kogai, T., Ohashi, E., Jacobs, M. S., Sajid-Crockett, S., Fisher, M. L., Kanamoto, Y., Brent, G. A. (2008). Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways. J. Clin. Endocrinol. Metab. 93: 1884-1892 [Abstract] [Full Text]  
• Tsai, W.-J. A., McCormick, K. M., Brazeau, D. A., Brazeau, G. A. (2007). Estrogen Effects on Skeletal Muscle Insulin-Like Growth Factor 1 and Myostatin in Ovariectomized Rats. Exp. Biol. Med. 232: 1314-1325 [Abstract] [Full Text]  
• Ravikumar, S., Perez-Liz, G., Del Vale, L., Soprano, D. R., Soprano, K. J. (2007). Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid. Cancer Res. 67: 9266-9275 [Abstract] [Full Text]  
• Lee, J. Y., Han, C. Y., Yang, J. W., Smith, C., Kim, S. K., Lee, E. Y.-H. P., Kim, S. G., Kang, K. W. (2007). Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells. Mol. Pharmacol. 72: 1082-1093 [Abstract] [Full Text]  
• vanTol, B. L., Missan, S., Crack, J., Moser, S., Baldridge, W. H., Linsdell, P., Cowley, E. A. (2007). Contribution of KCNQ1 to the regulatory volume decrease in the human mammary epithelial cell line MCF-7. Am. J. Physiol. Cell Physiol. 293: C1010-C1019 [Abstract] [Full Text]  
• Andreu-Vieyra, C., Chen, R., Matzuk, M. M. (2007). Effects of Granulosa Cell-Specific Deletion of Rb in Inha-{alpha} Null Female Mice. Endocrinology 148: 3837-3849 [Abstract] [Full Text]  
• Dhar, K., Banerjee, S., Dhar, G., Sengupta, K., Banerjee, S. K. (2007). Insulin-like Growth Factor-1 (IGF-1) Induces WISP-2/CCN5 via Multiple Molecular Cross-talks and Is Essential for Mitogenic Switch by IGF-1 Axis in Estrogen Receptor-Positive Breast Tumor Cells. Cancer Res. 67: 1520-1526 [Abstract] [Full Text]  
• Lorincz, A M, Sukumar, S (2006). Molecular links between obesity and breast cancer.. Endocr Relat Cancer 13: 279-292 [Abstract] [Full Text]  
• Cui, X., Kim, H.-J., Kuiatse, I., Kim, H., Brown, P. H., Lee, A. V. (2006). Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration.. Cancer Res. 66: 5304-5313 [Abstract] [Full Text]  
• Osipo, C., Meeke, K., Liu, H., Cheng, D., Lim, S., Weichel, A., Jordan, V. C. (2005). Trastuzumab Therapy for Tamoxifen-Stimulated Endometrial Cancer. Cancer Res. 65: 8504-8513 [Abstract] [Full Text]  
• Greco, S, Elia, M G, Muscella, A, Romano, S, Storelli, C, Marsigliante, S (2005). Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J Endocrinol 186: 291-301 [Abstract] [Full Text]  
• Koda, M, Sulkowska, M, Kanczuga-Koda, L, Sulkowski, S (2005). Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. J. Clin. Pathol. 58: 645-649 [Abstract] [Full Text]  
• Mendez, P., Azcoitia, I., Garcia-Segura, L. M. (2005). Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms. J Endocrinol 185: 11-17 [Abstract] [Full Text]  
• Chaturvedi, K., Sarkar, D. K. (2004). Involvement of Protein Kinase C-Dependent Mitogen-Activated Protein Kinase p44/42 Signaling Pathway for Cross-Talk between Estradiol and Transforming Growth Factor-{beta}3 in Increasing Basic Fibroblast Growth Factor in Folliculostellate Cells. Endocrinology 145: 706-715 [Abstract] [Full Text]  
• Boyd, D. B. (2003). Insulin and Cancer. Integr Cancer Ther 2: 315-329 [Abstract]  
• Eng-Wong, J., Hursting, S. D., Venzon, D., Perkins, S. N., Zujewski, J. A. (2003). Effect of Raloxifene on Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-3, and Leptin in Premenopausal Women at High Risk for Developing Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 12: 1468-1473 [Abstract] [Full Text]  
• Salas, T. R., Reddy, S. A., Clifford, J. L., Davis, R. J., Kikuchi, A., Lippman, S. M., Menter, D. G. (2003). Alleviating the Suppression of Glycogen Synthase Kinase-3{beta} by Akt Leads to the Phosphorylation of cAMP-response Element-binding Protein and Its Transactivation in Intact Cell Nuclei. J. Biol. Chem. 278: 41338-41346 [Abstract] [Full Text]  
• Decensi, A., Veronesi, U., Miceli, R., Johansson, H., Mariani, L., Camerini, T., Di Mauro, M. G., Cavadini, E., De Palo, G., Costa, A., Perloff, M., Malone, W. F., Formelli, F. (2003). Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide. Clin. Cancer Res. 9: 4722-4729 [Abstract] [Full Text]  
• Yu, H., Shu, X.-O., Li, B. D. L., Dai, Q., Gao, Y.-T., Jin, F., Zheng, W. (2003). Joint Effect of Insulin-like Growth Factors and Sex Steroids on Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 12: 1067-1073 [Abstract] [Full Text]  
• Cui, X., Zhang, P., Deng, W., Oesterreich, S., Lu, Y., Mills, G. B., Lee, A. V. (2003). Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast Cancer. Mol. Endocrinol. 17: 575-588 [Abstract] [Full Text]  
• Krajcik, R. A., Borofsky, N. D., Massardo, S., Orentreich, N. (2002). Insulin-like Growth Factor I (IGF-I), IGF-binding Proteins, and Breast Cancer. Cancer Epidemiol. Biomarkers Prev. 11: 1566-1573 [Abstract] [Full Text]  
• Vasudevan, N., Ogawa, S., Pfaff, D. (2002). Estrogen and Thyroid Hormone Receptor Interactions: Physiological Flexibility by Molecular Specificity. Physiol. Rev. 82: 923-944 [Abstract] [Full Text]  
• Shen, W.-H., Zhou, J.-H., Broussard, S. R., Freund, G. G., Dantzer, R., Kelley, K. W. (2002). Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor. Cancer Res. 62: 4746-4756 [Abstract] [Full Text]  
• Levenson, A. S., Svoboda, K. M., Pease, K. M., Kaiser, S. A., Chen, B., Simons, L. A., Jovanovic, B. D., Dyck, P. A., Jordan, V. C. (2002). Gene Expression Profiles with Activation of the Estrogen Receptor {alpha}-Selective Estrogen Receptor Modulator Complex in Breast Cancer Cells Expressing Wild-Type Estrogen Receptor. Cancer Res. 62: 4419-4426 [Abstract] [Full Text]  
• Stull, M. A., Richert, M. M., Loladze, A. V., Wood, T. L. (2002). Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells. Endocrinology 143: 1872-1879 [Abstract] [Full Text]